The Hourly View for CRSP
At the time of this writing, CRSP (Get Ratings)’s price is down $-0.61 (-0.48%) from the hour prior. It’s been a feast for bears operating on an hourly timeframe, as CRSP has now gone down 8 of the past 10 hours. If you’re a trend trader, consider that the strongest clear trend on the hourly chart exists on the 50 hour timeframe. The moving averages on the hourly timeframe suggest a choppiness in price, as the 20, 50, 100 and 200 are all in a mixed alignment — meaning the trend across timeframes is inconsistent, indicating a potential opportunity for rangebound traders.
CRSP’s Technical Outlook on the Daily Chart
At the moment, CRSP’s price is down $-5.4 (-4.12%) from the day prior. This is a reversal of the price action on the previous day, in which price moved up. As for the trend on the daily timeframe, we see the clearest trend on the 100 day timeframe. Most noteworthy in the world of moving averages on the daily chart is that the 20 day moving average has been crossed, with price now being below it. The moving averages on the daily timeframe suggest a choppiness in price, as the 20, 50, 100 and 200 are all in a mixed alignment — meaning the trend across timeframes is inconsistent, indicating a potential opportunity for rangebound traders. CRISPR Therapeutics AG’s price action over the past 90 days can be seen via the chart below.
For CRSP News Traders
Investors and traders in CRSP may be particularly interested in the following story that came out in the past day:
Gene-editing leader CRISPR Therapeutics (NASDAQ: CRSP) has generated sizzling returns for investors over the last 12 months. In this Motley Fool Live video, recorded on March 10, Fool.com contributors Keith Speights and Brian Orelli discuss whether or not CRISPR Therapeutics can soar nearly 30% from current levels as one top analyst predicts. J.P. Morgan set a one-year price target of $160 for CRISPR Therapeutics, and that’s nearly 30% above the stock’s current price.
Want More Great Investing Ideas?